FIELD: medicine. SUBSTANCE: this method prescribes carrying out hemosorption, 4 to 6 plasmapheretic procedures with medicamentous anti-inflammatory therapy and additionally intramuscularly administering calcitrine 12 to 24 h prior to hemosorption in daily amount of 3 to 5 units during 30 to 40 days. EFFECT: disclosed method allows minimizing probability of relapse by additionally administering calcitrine into patients suffering from complicated rheumatoid arthritis.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING RHEUMATIC ARTHRITIS | 1992 |
|
RU2038082C1 |
| METHOD TO CHOOSE EFFERENT THERAPY AT RHEUMATOID ARTHRITIS | 1994 |
|
RU2089221C1 |
| METHOD FOR EVALUATION OF RHEUMATOID ARTHRITIS TREATMENT EFFECTIVENESS | 0 |
|
SU1691752A1 |
| METHOD OF TREATING RHEUMATOID ARTHRITIS | 2011 |
|
RU2476248C2 |
| METHOD OF TREATING RHEUMATOID ARTHRITIS | 2012 |
|
RU2504410C1 |
| METHOD FOR EVALUATING EFFICIENCY OF TREATMENT OF RHEUMATOID ARTHRITIS | 1994 |
|
RU2088930C1 |
| 0 |
|
SU1779997A1 | |
| METHOD OF TREATING PATIENTS WITH RHEUMATOID ARTHRITIS | 2013 |
|
RU2537889C1 |
| METHOD OF ANALYSING INDIVIDUAL SENSITIVITY OF PLASMAPHERESIS FOR RHEUMATIC ARTHRITIS PATIENTS | 0 |
|
SU1476386A1 |
| METHOD FOR TREATING ATYPICAL FORM OF PSORIASIS | 2000 |
|
RU2200594C2 |
